Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy

Bibliographic Details
Title: Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy
Authors: Ying Xu, Yu Liu, Miaoxian Zhao, Yunqing Chen, Cantao Xie, Mingxing Gong, Haohui Deng, Xueying Li, Jian Sun, Jinlin Hou, Hongkai Wu, Zhanhui Wang
Source: Frontiers in Immunology, Vol 8 (2017)
Publisher Information: Frontiers Media S.A., 2017.
Publication Year: 2017
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: high-throughput sequencing, chronic hepatitis B infection, nucleos(t)ide analogs, hepatitis B e antigen seroconversion, T cell receptor, Immunologic diseases. Allergy, RC581-607
More Details: Long-term treatment with nucleos(t)ide analogs (NUCs) can improve the antiviral T cell response in chronic hepatitis B (CHB) patients. Whether and to what extent the T cell response is improved by NUCs in the early stage leading to hepatitis B e antigen (HBeAg) seroconversion remain to be clarified. A total of 22 CHB patients undergoing 2-year telbivudine-based therapy were enrolled, including 10 exhibiting a complete response (CR) and 12 exhibiting a non-complete response (NCR) according to HBeAg seroconversion at week 52. Peripheral CD4+ and CD8+ T cells were sorted at baseline, weeks 12, and 24. The T cell receptor β chain (TCRβ) complementarity-determining region 3 was analyzed by unbiased high-throughput sequencing. Compared with NCR group, patients in CR group had a much lower percentage of persistent clonotypes (P
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: http://journal.frontiersin.org/article/10.3389/fimmu.2017.01142/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2017.01142
Access URL: https://doaj.org/article/3080f6c3b28048f8b5e628a462a8ff9a
Accession Number: edsdoj.3080f6c3b28048f8b5e628a462a8ff9a
Database: Directory of Open Access Journals
More Details
ISSN:16643224
DOI:10.3389/fimmu.2017.01142
Published in:Frontiers in Immunology
Language:English